Endologix, Inc. to Present at the J.P. Morgan Healthcare Conference
03 January 2020 - 8:01AM
Business Wire
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of
innovative treatments for aortic disorders, today announced that
John Onopchenko, Chief Executive Officer, and Vaseem Mahboob, Chief
Financial Officer, will present at the 38th Annual J.P. Morgan
Healthcare Conference at 7:30 a.m. PT on Thursday, January 16, 2020
in San Francisco, CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.endologix.com and will be available for replay
following the event.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
80%, making it a leading cause of death in the United States. For
more information, visit www.endologix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200102005491/en/
INVESTOR CONTACT: Endologix, Inc. Vaseem Mahboob, CFO
(949) 595-7200
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Endologix Inc (NASDAQ): 0 recent articles
More Endologix, Inc. News Articles